Nonhuman primate transplant models finally evolve: Detailed immunogenetic analysis creates new models and strengthens the old

American Journal of Transplantation

Volumn 12, Issue 4, 2012, Pages 812-819

  Kean, Leslie S ^a,b   Singh, K ^b   Blazar, B R ^c   Larsen, C P ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

MHC; Nonhuman primate; Transplant

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MICROSATELLITE DNA;

ALLELE; ALLOIMMUNITY; CHROMOSOME 6; CHROMOSOME STRUCTURE; DEATH; DIGESTIVE SYSTEM INJURY; GENE EXPRESSION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGENETICS; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; MACACA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; NONHUMAN; NONHUMAN PRIMATE; ORGAN TRANSPLANTATION; PATIENT CARE; PRIMATE; PRIORITY JOURNAL; PYROSEQUENCING; SHORT SURVEY;

ANIMALS; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; IMMUNOGENETICS; ORGAN TRANSPLANTATION; PRIMATES;

EID: 84859420445     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03873.x     Document Type: Short Survey

References (39)

1. Kawai T, Abrahamian G, Sogawa H, et al. Costimulatory blockade for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Transplant Proc 2001; 33: 221-222. (Pubitemid 32237343)
2. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94: 8789-8794. (Pubitemid 27335118)
3. Larsen CP, Pearson TC, Adams AB, et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 2005; 5: 443-453. (Pubitemid 40313335)
4. Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10: 535-546.
5. Weaver TA, Charafeddine AH, Agarwal A, et al. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med 2009; 15: 746-749.
6. Adams AB, Shirasugi N, Jones TR, et al. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol 2005; 174: 542-550. (Pubitemid 40007445)
7. Aoyagi T, Yamashita K, Suzuki T, et al. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: Induction and maintenance therapy. Am J Transplant 2009; 9: 1732-1741.
8. Badell IR, Russell MC, Thompson PW, et al. LFA-1-specific therapy prolongs allograft survival in rhesus macaques. J Clin Invest 2010; 120: 4520-4531.
9. Graves SS, Stone D, Loretz C, et al. Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig. Transplantation. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't] 2009; 88: 317-322.
10. Graves SS, Stone DM, Loretz C, et al. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation. Transplantation. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't] 2011; 91: 833-840.
11. Jochum C, Beste M, Stone D, Graves SS, Storb R. Development and in vitro characterization of canine CD40-Ig. Vet Immunol Immunopathol. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't] 2008; 123: 260-265.
12. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6: 114. (Pubitemid 30082329)
13. Kirk AD. Crossing the bridge: large animal models in translational transplantation research. Immunol Rev 2003; 196: 176-196. (Pubitemid 37468111)
14. Kirk AD. Clinical tolerance 2008. Transplantation 2009; 87: 953-955.
15. Pearson TC, Trambley J, Odom K, et al. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 2002; 74: 933-940. (Pubitemid 35191239)
16. Yu C, Linsley P, Seidel K, et al. Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model. Transplantation 2000; 69: 450-454. (Pubitemid 30118133)
17. Bonhomme M, Doxiadis GG, Heijmans CM, et al. Genomic plasticity of the immune-related Mhc class I B region in macaque species. BMC Genomics [Research Support, Non-U.S. Gov't] 2008; 9: 514-525.
18. Daza-Vamenta R, Glusman G, Rowen L, Guthrie B, Geraghty DE. Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res [Comparative Study Research Support, U.S. Gov't, P.H.S.] 2004; 14: 1501-1515.
19. de Groot N, Doxiadis GG, De Groot NG, et al. Genetic makeup of the DR region in rhesus macaques: gene content, transcripts, and pseudogenes. J Immunol [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] 2004; 172: 6152-6157.
20. Doxiadis GG, Heijmans CM, Bonhomme M, Otting N, Crouau-Roy B, Bontrop RE. Compound evolutionary history of the rhesus macaque MHC class I B region revealed by microsatellite analysis and localization of retroviral sequences. PLoS One [Research Support, N.I.H., Extramural] 2009; 4: e4287.
21. Doxiadis GG, Heijmans CM, Otting N, Bontrop RE. MIC gene polymorphism and haplotype diversity in rhesus macaques. Tissue Antigens [Research Support, N.I.H., Extramural] 2007; 69: 212-219.
22. Gibbs RA, Rogers J, Katze MG, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science [Research Support, N.I.H., Extramural] 2007; 316: 222-234.
23. Ma X, Tang LH, Qu LB, Ma J, Chen L. Identification of 17 novel major histocompatibility complex-A alleles in a population of Chinese-origin rhesus macaques. Tissue Antigens [Research Support, Non-U.S. Gov't] 2009; 73: 184-187.
24. Otting N, de Vos-Rouweler AJ, Heijmans CM, de Groot NG, Doxiadis GG, Bontrop RE. MHC class I A region diversity and polymorphism in macaque species. Immunogenetics [Comparative Study Research Support, N.I.H., Extramural] 2007; 59: 367-375.
25. Otting N, Heijmans CM, Noort RC, et al. Unparalleled complexity of the MHC class I region in rhesus macaques. Proc Natl Acad Sci U S A [Research Support, U.S. Gov't, P.H.S.] 2005; 102: 1626-1631.
26. Otting N, Heijmans CM, van der Wiel M, de Groot NG, Doxiadis GG, Bontrop RE. A snapshot of the Mamu-B genes and their allelic repertoire in rhesus macaques of Chinese origin. Immunogenetics [Research Support, N.I.H., Extramural] 2008; 60: 507-514.
27. Rogers J, Garcia R, Shelledy W, et al. An initial genetic linkage map of the rhesus macaque (Macaca mulatta) genome using human microsatellite loci. Genomics [Comparative Study Research Support, N.I.H., Extramural] 2006; 87: 30-38.
28. Karl JA, Wiseman RW, O'Connor DH. Cost-effective sequence-based nonhuman primate MHC class I genotyping from RNA. Methods [Research Support, N.I.H., Extramural] 2009; 49: 11-17.
29. Andrade MC, Penedo MC, Ward T, et al. Determination of genetic status in a closed colony of rhesus monkeys (Macaca mulatta). Primates 2004; 45: 183-186. (Pubitemid 39447750)
30. Penedo MC, Bontrop RE, Heijmans CM, et al. Microsatellite typing of the rhesus macaque MHC region. Immunogenetics 2005; 57: 198-209. (Pubitemid 40775577)
31. Wiseman RW, Karl JA, Bimber BN, et al. Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med 2009; 15: 1322-1326.
32. Berman DM, Willman MA, Han D, et al. Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes [Research Support, N.I.H., Extramural] 2010; 59: 2558-2568.
33. Larsen CP, Page A, Linzie KH, et al. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am J Transplant 2010; 10: 2396-2409.
34. Nadazdin O, Boskovic S, Murakami T, et al. Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant [Research Support, N.I.H., Extramural] 2010; 10: 1375-1384.
35. Miller WP, Srinivasan S, Panoskaltsis-Mortari A, et al. GvHD after haploidentical transplant: a novel, MHC-defined rhesus macaque model identifies CD28-negative CD8+ T cells as a reservoir of breakthrough T cell proliferation during costimulation blockade and sirolimus-based immunosuppression. Blood 2010; 116: 5403-5318.
36. Nadazdin O, Boskovic S, Murakami T, et al.Host alloreactivememory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med 2011; 3: 86ra51.
37. Page A, Srinivasan S, Singh K, et al. CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am J Transplant 2010; 10: 2396-2409.
38. Scheinberg P, Price DA, Ambrozak DR, Barrett AJ, Douek DC. Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: Implications for graft engineering. Exp Hematol [Research Support, N.I.H., Intramural]. 2006; 34: 788-795.
39. Johnson ZP, Eady RD, Ahamad SF, et al. Immunogenetic Management Software: A new tool for visualization and analysis of complex immunogenetic datasets. Immunogenetics 2011; November 15 (Epub ahead of print).